Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD

Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD

Long-term, low-dose azithromycin reduces exacerbation frequency in chronic obstructive pulmonary disease (COPD), yet the mechanism remains unclear. This study characterised genome-wide gene expression changes in patients with neutrophilic COPD following long-term, low-dose azithromycin treatment. Pa...

Full description

Bibliographic Details
Main Authors: Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson
Format: Article
Language:English
Published: European Respiratory Society 2018-11-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/4/4/00031-2018.full

Internet

http://openres.ersjournals.com/content/4/4/00031-2018.full

Similar Items